These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 3183418)

  • 21. In vitro and in vivo antifungal activities of liposomal amphotericin B, and amphotericin B lipid complex.
    Mitsutake K; Kohno S; Miyazaki Y; Noda T; Miyazaki H; Miyazaki T; Kaku M; Koga H; Hara K
    Mycopathologia; 1994 Oct; 128(1):13-7. PubMed ID: 7708087
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Toxicity, stability and pharmacokinetics of amphotericin B in immunomodulator tuftsin-bearing liposomes in a murine model.
    Khan MA; Owais M
    J Antimicrob Chemother; 2006 Jul; 58(1):125-32. PubMed ID: 16709592
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy of alternative dosing regimens of poly-aggregated amphotericin B.
    Espada R; Valdespina S; Molero G; Dea MA; Ballesteros MP; Torrado JJ
    Int J Antimicrob Agents; 2008 Jul; 32(1):55-61. PubMed ID: 18534826
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treatment of systemic candidiasis in a neutropenic murine model using immunoglobulin G bearing liposomal amphotericin B.
    Belay T; Hospenthal DR; Rogers AL; Patterson MJ
    Mycopathologia; 1993 Jul; 123(1):9-17. PubMed ID: 8247096
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Polysaccharide-coated liposomal amphotericin B for the treatment of murine pulmonary candidiasis.
    Miyazaki T; Kohno S; Sasayama K; Inoue Y; Hara K; Ogasawara M; Sato T; Sunamoto J
    Tohoku J Exp Med; 1992 Nov; 168(3):483-90. PubMed ID: 1304655
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of amphotericin B incorporated into liposomes and in lipid suspensions in the treatment of murine candidiasis.
    Kretschmar M; Nichterlein T; Hannak D; Hof H
    Arzneimittelforschung; 1996 Jul; 46(7):711-5. PubMed ID: 8842344
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Use of amphotericin B in lipid emulsions: does it prevent its toxicity in critically ill patients?].
    Hernández G; Altermatt F; Bernucci F; Acuña D; Apablaza F; Valenzuela F; Lefio A; Pérez C; Bugedo G; Castillo L
    Rev Med Chil; 2000 Oct; 128(10):1101-7. PubMed ID: 11349508
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Activity, reduced toxicity, and scale-up synthesis of amphotericin B-conjugated polysaccharide.
    Ickowicz DE; Farber S; Sionov E; Kagan S; Hoffman A; Polacheck I; Domb AJ
    Biomacromolecules; 2014 Jun; 15(6):2079-89. PubMed ID: 24779556
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Decrease in Fungizone toxicity induced by the use of Lipofundin as a dilutent: an in vitro study.
    de Araújo IB; Damasceno BP; de Medeiros TM; Soares LA; do Egito ES
    Curr Drug Deliv; 2005 Apr; 2(2):199-205. PubMed ID: 16305421
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of the activity of free and liposomal amphotericin B in vitro and in a model of systemic and localized murine candidiasis.
    Pahls S; Schaffner A
    J Infect Dis; 1994 May; 169(5):1057-61. PubMed ID: 8169391
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Treatment of a murine model of systemic candidiasis with liposomal amphotericin B bearing antibody to Candida albicans.
    Hospenthal D; Gretzinger K; Rogers A
    J Med Microbiol; 1989 Nov; 30(3):193-7. PubMed ID: 2685314
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The use of commercially available lipid emulsions for the preparation of amphotericin B-lipid admixtures.
    Shadkhan Y; Segal E; Bor A; Gov Y; Rubin M; Lichtenberg D
    J Antimicrob Chemother; 1997 May; 39(5):655-8. PubMed ID: 9184368
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy of a new formulation of amphotericin B in murine disseminated infections by Candida glabrata or Candida tropicalis.
    Mariné M; Espada R; Torrado J; Pastor FJ; Guarro J
    Int J Antimicrob Agents; 2009 Dec; 34(6):566-9. PubMed ID: 19733036
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Administration of amphotericin B in lipid emulsion decreases nephrotoxicity: results of a prospective, randomized, controlled study in critically ill patients.
    Sorkine P; Nagar H; Weinbroum A; Setton A; Israitel E; Scarlatt A; Silbiger A; Rudick V; Kluger Y; Halpern P
    Crit Care Med; 1996 Aug; 24(8):1311-5. PubMed ID: 8706484
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficacy of a new formulation of amphotericin B in a murine model of disseminated infection by Candida glabrata.
    Mariné M; Espada R; Torrado J; Pastor FJ; Guarro J
    J Antimicrob Chemother; 2008 Apr; 61(4):880-3. PubMed ID: 18256113
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vivo distribution and therapeutic efficacy of a novel amphotericin B poly-aggregated formulation.
    Espada R; Valdespina S; Dea MA; Molero G; Ballesteros MP; Bolás F; Torrado JJ
    J Antimicrob Chemother; 2008 May; 61(5):1125-31. PubMed ID: 18285313
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treatment of Candida glabrata infection in immunosuppressed mice by using a combination of liposomal amphotericin B with caspofungin or micafungin.
    Olson JA; Adler-Moore JP; Smith PJ; Proffitt RT
    Antimicrob Agents Chemother; 2005 Dec; 49(12):4895-902. PubMed ID: 16304150
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Case-control study of amphotericin B in a triglyceride fat emulsion versus conventional amphotericin B in patients with AIDS.
    Manfredi R; Chiodo F
    Pharmacotherapy; 1998; 18(5):1087-92. PubMed ID: 9758320
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficacy and tolerance of an amphotericin B lipid (Intralipid) emulsion in the treatment of candidaemia in neutropenic patients.
    Caillot D; Casasnovas O; Solary E; Chavanet P; Bonnotte B; Reny G; Entezam F; Lopez J; Bonnin A; Guy H
    J Antimicrob Chemother; 1993 Jan; 31(1):161-9. PubMed ID: 8444659
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatment of experimental murine candidiasis with liposome-associated amphotericin B.
    Ahrens J; Graybill JR; Craven PC; Taylor RL
    Sabouraudia; 1984; 22(2):163-6. PubMed ID: 6729660
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.